In contrast, BRAF gene mutations have been found in 5%–15% of CRC cases; are more common in older patients, women, and right‐sided colon cancers, and are characterized by a high frequency of advanced cancer, resistance to chemotherapy, and poor prognosis.7 Here, BRAF is linked to cancer.